{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:37:29Z","timestamp":1783535849231,"version":"3.55.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017585","name":"First Hospital of Jilin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017585","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrc.2025.152504","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:09:30Z","timestamp":1755493770000},"page":"152504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Aberrant glycosylation in pulmonary fibrosis: Mechanisms, biomarkers, and treatment opportunities"],"prefix":"10.1016","volume":"781","author":[{"given":"Deqiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanjie","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9387-3007","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7835","key":"10.1016\/j.bbrc.2025.152504_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2025.152504_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101191","article-title":"Mechanisms of organ fibrosis: emerging concepts and implications for novel treatment strategies","volume":"92","author":"Lurje","year":"2023","journal-title":"Mol. Aspect. Med."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152504_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2025.152504_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2018.06.003","article-title":"Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications","volume":"65","author":"Weiskirchen","year":"2019","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.bbrc.2025.152504_bib5","first-page":"301","article-title":"Fibroblasts and myofibroblasts in wound healing","volume":"7","author":"Darby","year":"2014","journal-title":"Clin. Cosmet. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152504_bib6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.stem.2022.07.006","article-title":"Wound healing, fibroblast heterogeneity, and fibrosis","volume":"29","author":"Talbott","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2025.152504_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation","volume":"15","author":"Zindel","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41573-019-0040-5","article-title":"Targeting metabolic dysregulation for fibrosis therapy","volume":"19","author":"Zhao","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152504_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152504_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.immuni.2021.04.021","article-title":"Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer","volume":"54","author":"Buechler","year":"2021","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.bbrc.2025.152504_bib11","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41581-021-00415-5","article-title":"Key metalloproteinase-mediated pathways in the kidney","volume":"17","author":"Wozniak","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12964-023-01040-4","article-title":"Endothelial cell-derived MMP19 promotes pulmonary fibrosis by inducing E(nd)MT and monocyte infiltration","volume":"21","author":"Zhao","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrc.2025.152504_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trsl.2017.09.005","article-title":"Reactive oxygen species as signaling molecules in the development of lung fibrosis","volume":"190","author":"Gonzalez-Gonzalez","year":"2017","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152504_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00407-2023","article-title":"Endothelial cells in pulmonary fibrosis: more than a bystander","volume":"61","author":"Yanagihara","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152504_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01799-2022","article-title":"Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis","volume":"61","author":"Wu","year":"2023","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbrc.2025.152504_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coi.2019.11.004","article-title":"Epithelial cells: liaisons of immunity","volume":"62","author":"Larsen","year":"2020","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152504_bib17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ymthe.2019.02.009","article-title":"MicroRNA-34a promotes renal fibrosis by downregulation of Klotho in tubular epithelial cells","volume":"27","author":"Liu","year":"2019","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152504_bib18","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.ymthe.2024.02.024","article-title":"Osr1-mediated mesothelial transition of liver mesenchymal cells exacerbates fibrotic liver damage","volume":"32","author":"Nian","year":"2024","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/qjmed\/hcu067","article-title":"Healing scars: targeting pericytes to treat fibrosis","volume":"108","author":"Greenhalgh","year":"2015","journal-title":"QJM"},{"issue":"15","key":"10.1016\/j.bbrc.2025.152504_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155203","article-title":"The roles of immune cells in the pathogenesis of fibrosis","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152504_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152504_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","article-title":"Global view of human protein glycosylation pathways and functions","volume":"21","author":"Schjoldager","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.152504_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1168023","article-title":"Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases","volume":"14","author":"Xie","year":"2023","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.bbrc.2025.152504_bib24","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1039\/C5CS00600G","article-title":"Glycosyltransferases: mechanisms and applications in natural product development","volume":"44","author":"Liang","year":"2015","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"10.1016\/j.bbrc.2025.152504_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152504_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000263","article-title":"Heterogenic endothelial responses to inflammation: role for differential N-glycosylation and vascular bed of origin","volume":"2","author":"Scott","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152504_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100761","article-title":"Systematic investigation of the trafficking of glycoproteins on the cell surface","volume":"23","author":"Xu","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"issue":"14","key":"10.1016\/j.bbrc.2025.152504_bib29","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.7150\/thno.43865","article-title":"MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152504_bib30","doi-asserted-by":"crossref","first-page":"29R","DOI":"10.1093\/glycob\/cwj016","article-title":"Structures and mechanisms of glycosyltransferases","volume":"16","author":"Breton","year":"2006","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152504_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0959-440X(97)80072-3","article-title":"Structural and sequence-based classification of glycoside hydrolases","volume":"7","author":"Henrissat","year":"1997","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"Database issue","key":"10.1016\/j.bbrc.2025.152504_bib32","doi-asserted-by":"crossref","first-page":"D490","DOI":"10.1093\/nar\/gkt1178","article-title":"The carbohydrate-active enzymes database (CAZy) in 2013","volume":"42","author":"Lombard","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.152504_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev.biochem.66.1.315","article-title":"Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins","volume":"66","author":"Hart","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrc.2025.152504_bib34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1146\/annurev-biochem-060608-102511","article-title":"Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease","volume":"80","author":"Hart","year":"2011","journal-title":"Annu. Rev. Biochem."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152504_bib35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.20161105","article-title":"Myeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation","volume":"214","author":"Li","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2025.152504_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105910","article-title":"Epigenetic regulation in fibrosis progress","volume":"173","author":"Xue","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152504_bib37","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: from pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"issue":"9807","key":"10.1016\/j.bbrc.2025.152504_bib38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2025.152504_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1328781","article-title":"Metabolism-driven glycosylation represents therapeutic opportunities in interstitial lung diseases","volume":"15","author":"Drzewicka","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152504_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583042","article-title":"Cross-talk between alveolar macrophages and lung epithelial cells is essential to maintain lung homeostasis","volume":"11","author":"Bissonnette","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.152504_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104591","article-title":"Matrix metalloproteinase: an upcoming therapeutic approach for idiopathic pulmonary fibrosis","volume":"152","author":"Mahalanobish","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23543","article-title":"Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis","volume":"10","author":"Zhu","year":"2024","journal-title":"Heliyon"},{"issue":"13","key":"10.1016\/j.bbrc.2025.152504_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136894","article-title":"Matrix metalloproteinases and their inhibitors in pulmonary fibrosis: EMMPRIN\/CD147 comes into play","volume":"23","author":"Chuli\u00e1-Peris","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.bbrc.2025.152504_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10143167","article-title":"Serum biomarkers in differential diagnosis of idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung disease","volume":"10","author":"Cabrera Cesar","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152504_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050093","article-title":"MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"5","author":"Rosas","year":"2008","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152504_bib46","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.humpath.2006.03.006","article-title":"Extracellular matrix metalloproteinase inducer in interstitial pneumonias","volume":"37","author":"Odajima","year":"2006","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152504_bib47","first-page":"2276","article-title":"Regulation of MMP-1 and MMP-2 production through CD147\/extracellular matrix metalloproteinase inducer interactions","volume":"61","author":"Sun","year":"2001","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.5054","article-title":"N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147\/basigin with integrin \u03b21 and promotes HCC metastasis","volume":"245","author":"Cui","year":"2018","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152504_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/BJ20120343","article-title":"Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation","volume":"449","author":"Huang","year":"2013","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.bbrc.2025.152504_bib50","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.3390\/ijms15046356","article-title":"Importance of N-glycosylation on CD147 for its biological functions","volume":"15","author":"Bai","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbrc.2025.152504_bib51","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00418-006-0192-3","article-title":"Lack of evidence for caveolin-1 and CD147 interaction before and after bleomycin-induced lung injury","volume":"126","author":"Barth","year":"2006","journal-title":"Histochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152504_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082098","article-title":"High glucose and advanced glycation end products induce CD147-Mediated MMP activity in human adipocytes","volume":"10","author":"Mahmoud","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib53","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41392-022-01230-5","article-title":"CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis","volume":"7","author":"Wu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","article-title":"Emerging therapeutic opportunities for integrin inhibitors","volume":"21","author":"Slack","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152504_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.matbio.2014.08.001","article-title":"Post-translational modifications of integrin ligands as pathogenic mechanisms in disease","volume":"40","author":"Zeltz","year":"2014","journal-title":"Matrix Biol."},{"issue":"12","key":"10.1016\/j.bbrc.2025.152504_bib56","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1172\/JCI64100","article-title":"Gain of glycosylation in integrin \u03b13 causes lung disease and nephrotic syndrome","volume":"122","author":"Nicolaou","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"14","key":"10.1016\/j.bbrc.2025.152504_bib57","doi-asserted-by":"crossref","first-page":"18852","DOI":"10.18632\/aging.203335","article-title":"Regulation of the IGF1 signaling pathway is involved in idiopathic pulmonary fibrosis induced by alveolar epithelial cell senescence and core fucosylation","volume":"13","author":"Sun","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.bbrc.2025.152504_bib58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s43657-023-00096-z","article-title":"\u03b12,3-Sialylation with fucosylation associated with more severe Anti-MDA5 positive dermatomyositis induced by rapidly progressive interstitial lung disease","volume":"3","author":"Zhang","year":"2023","journal-title":"Phenomics"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152504_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.86","article-title":"BAX inhibitor-1-associated V-ATPase glycosylation enhances collagen degradation in pulmonary fibrosis","volume":"5","author":"Lee","year":"2014","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbrc.2025.152504_bib60","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/stmcls\/sxae044","article-title":"BMSCs promote alveolar epithelial cell autophagy to reduce pulmonary fibrosis by inhibiting core fucosylation modifications","volume":"42","author":"Hu","year":"2024","journal-title":"Stem Cell."},{"key":"10.1016\/j.bbrc.2025.152504_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.intimp.2017.04.024","article-title":"Synergistic protection of schizandrin B and glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-\u03b21\/Smad2 pathways and overexpression of NOX4","volume":"48","author":"Zhang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2025.152504_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105639","article-title":"The effect of core fucosylation-mediated regulation of multiple signaling pathways on lung pericyte activation and fibrosis","volume":"117","author":"Sun","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152504_bib63","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03979-2020","article-title":"Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study","volume":"59","author":"Nakanishi","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"36","key":"10.1016\/j.bbrc.2025.152504_bib64","article-title":"O-GlcNAcylation regulates centrosome behavior and cell polarity to reduce pulmonary fibrosis and maintain the epithelial phenotype","volume":"10","author":"Yu","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bbrc.2025.152504_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1387197","article-title":"O-GlcNAc transferase regulates collagen deposition and fibrosis resolution in idiopathic pulmonary fibrosis","volume":"15","author":"Vang","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152504_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18191","article-title":"O-GlcNAc regulates anti-fibrotic genes in lung fibroblasts through EZH2","volume":"28","author":"Wu","year":"2024","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010239","article-title":"Inhibitors of the sialidase NEU3 as potential therapeutics for fibrosis","volume":"24","author":"Karhadkar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.120.000258","article-title":"Inhibiting sialidase-induced TGF-\u03b21 activation attenuates pulmonary fibrosis in mice","volume":"376","author":"Karhadkar","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"19","key":"10.1016\/j.bbrc.2025.152504_bib69","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.1074\/jbc.M112.346817","article-title":"NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not","volume":"287","author":"Cross","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/jpet.120.000223","article-title":"Therapeutic effect of Neuraminidase-1-Selective inhibition in mouse models of bleomycin-induced pulmonary inflammation and fibrosis","volume":"376","author":"Luzina","year":"2021","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib71","doi-asserted-by":"crossref","first-page":"L165","DOI":"10.1152\/ajplung.00275.2019","article-title":"Attenuated pulmonary fibrosis in sialidase-3 knockout (Neu3-\/-) mice","volume":"318","author":"Karhadkar","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12931-022-02146-y","article-title":"The sialidase NEU3 promotes pulmonary fibrosis in mice","volume":"23","author":"Pilling","year":"2022","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152504_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030905","article-title":"Galectins as molecular targets for therapeutic intervention","volume":"19","author":"Dings","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.152504_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154680","article-title":"Hesperidin inhibits lung fibroblast senescence via IL-6\/STAT3 signaling pathway to suppress pulmonary fibrosis","volume":"112","author":"Han","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2025.152504_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105881","article-title":"The therapeutic potential of galectin-3 inhibition in fibrotic disease","volume":"130","author":"Slack","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010239","article-title":"Inhibitors of the sialidase NEU3 as potential therapeutics for fibrosis","volume":"24","author":"Karhadkar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152504_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15198-8","article-title":"Sialidase inhibitors attenuate pulmonary fibrosis in a mouse model","volume":"7","author":"Karhadkar","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbrc.2025.152504_bib78","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1073\/pnas.1220425110","article-title":"Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer","volume":"110","author":"Chen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"44","key":"10.1016\/j.bbrc.2025.152504_bib79","doi-asserted-by":"crossref","first-page":"15791","DOI":"10.1073\/pnas.0507375102","article-title":"Dysregulation of TGF-beta 1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25012197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25012197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:23:58Z","timestamp":1775834638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25012197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":79,"alternative-id":["S0006291X25012197"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152504","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant glycosylation in pulmonary fibrosis: Mechanisms, biomarkers, and treatment opportunities","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152504"}}